Incidence of radioiodine induced Graves' disease in patients with multinodular toxic goiter

Experimental and Clinical Endocrinology and Diabetes

Volumn 114, Issue 5, 2006, Pages 235-239

  Meller, Johannes ^a   Siefker, U ^a   Hamann, A ^a   Hufner M ^a  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

Autoimmunity; Disseminated autonomy; Graves' disease; Radioiodine therapy (RIT); Toxic multinodular goiter; TSH receptor antibodies

Indexed keywords

IODINE 131; LIOTHYRONINE; THIONAMIDE; THYROID PEROXIDASE; THYROTROPIN; THYROTROPIN RECEPTOR ANTIBODY;

ADULT; ARTICLE; CONTROLLED STUDY; ECHOGRAPHY; FEMALE; FOLLOW UP; GOITER; GRAVES DISEASE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; THYROID HORMONE BLOOD LEVEL; THYROID SCINTISCANNING;

ADULT; AGED; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; GOITER, NODULAR; GRAVES DISEASE; HUMANS; INCIDENCE; IODINE RADIOISOTOPES; MALE; MIDDLE AGED; RADIATION INJURIES; RADIOTHERAPY DOSAGE; RETROSPECTIVE STUDIES;

EID: 33746009982     PISSN: 09477349     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2006-924239     Document Type: Article

References (28)

1. Bartalena L, Bogazzi F, Pecori F, Martino E. Graves' disease occurring after subacute thyroiditis: report of a case and review of the literature. Thyroid 1996; 6: 345-348
2. Bähre M, Hilgers R, Lindemann C, Emrich D. Thyroid autonomy: sensitive detection and estimation of its functional relevance using quantified high-resolution scintigraphy. Acta Endocrinol (Copenh) 1988; 117: 145-153
3. Becker W, Frank R, Börner W. Bedeutung einer quantitativen Grauwertanalyse des Sonogramms bei "diffusen" Erkrankungen der Schilddrüse. Fortschr Röntgenstr 1989; 150: 66-71
4. Castagliola S, Morgenthaler NG, Hoermann R, Badenhoop K, Struck J, Freitag D, Poertl S, Weglöhner W, Hollidt JM, Quadbeck B, Dumont JE, Schumm-Draeger PM, Bergmann A, Mann K, Vassart G, Usadel KH. Second generation assay for thyrotropin receptor antibodies has superior sensitivity for Graves' disease. J Clin Endocrinol Metab 1999; 84: 90-97
5. DeGroot LJ. Radioiodine and the immune system. Thyroid 1997; 7: 259-264
6. Dunkelmann S, Endlicher D, Prillwitz A, Rudolph F, Groth P, Schuemichen C. Results of TcTUs-optimized radioiodine therapy of multifocal and disseminated functional thyroid autonomy. Nuklearmedizin 1999; 38: 131-139
7. Dunkelmann S, Wolf R, Koch A, Kittner C, Groth P, Schuemichen C. Incidence of radiation-induced Graves' disease in patients treated with radioiodine for thyroid autonomy before and after introduction of a high-sensitivity TSH receptor antibody assay. Eur J Nucl Med Mol Imaging 2004; 31: 1428-1434
8. Emrich D, Erlenmaier U, Pohl M, Luig H. Determination of the autonomously functioning volume of the thyroid. Eur J Nucl Med 1993; 20: 410-414
9. Freeman JS, Ertel NH, McA'Nulty JA, Khan MY. Graves' disease following resection of an autonomous solitary thyroid adenoma. J Med Soc NY 1983; 80: 444-446
10. Kraiem Z, Glaser B, Yigla M, Pauker J, Sadeh O, Sheinfeld M. Toxic multinodular goiter: a variant of autoimmune hyperthyroidism. Clin Endocrinol Metab 1987; 65: 659-664
11. Meller J, Jauho A, Hüfner M, Gratz S, Becker W. Disseminated thyroid autonomy versus graves disease: reevaluation by a second generation TSH-receptor-antibody assay. Thyroid 2000 a; 10: 1085-1091
12. Meller J, Schreivogel I, Bergmann A, Morgenthaler N, Hüfner M, Becker W. Klinische Implikationen eines neuen TSH-Rezeptor-Antikörper- Assays (DYNOtest® TRAKhuman) bei autoimmunen Schilddrüsenerkrankungen. Nuklearmedizin 2000 b; 39: 14-18
13. Meller J, Hüfner M, Krohn K, Paschke R, Becker W. Disseminierte Autonomie (DISA): Eine TRAk-negative Autoimmunhyperthyreose? In: Mann K, Weinheimer B, Janssen OE (eds). Schilddrüse 2001. Berlin: de Gruyter, 2002 a: 139-148
14. Meller J, Sahlmann CO, Becker W. Radioidine treatment of functional thyroidal autonomy. Nucl Med Rev Cent East Eur 2002 b; 5: 1-10
15. Meller J, Becker W. The continuing importance of thyroid scintigraphy in the era of high resolution ultrasound. Eur J Nucl Med 2002; 29: S425-S438
16. Nygaard B, Knudsen JH, Hegedues L, Veje A, Hansen JEM. Thyrotropin receptor antibodies and Graves' disease, a side effect of 131I treatment in patients with non-toxic goiter. J Clin Endocrinol Metab 1997; 82: 2926-2930
17. Nygaard B, Metcalfe RA, Phipps J, Weetman AP, Hegedus L. Graves' disease and thyroid associated ophthalmopathy triggered by 131I treatment of non-toxic goiter. J Endocrinol Invest 1999 a; 22: 481-485
18. Nygaard B, Faber J, Veje A, Hegedus L, Hansen JM. Transition of nodular toxic goiter to autoimmune hyperthyroidism triggered by 131I therapy. Thyroid 1999 b; 9: 477-481
19. Orsolon P, Lupi A, De Antoni Migliorati G, Vianello Dri A. Appearance of Graves' disease following regression of autonomously functioning thyroid nodules. Two case reports. Minerva Endocrinol 1998; 23: 53-56
20. Pohl M, Emrich D. Immunogene und nicht immunogene Hyperthyreose - Ein Vergleich. Nuklearmedizin 1993; 32: 200-205
21. Scherbaum WA, Paschke R. Bedeutung der Schilddrüsenantikörper für Diagnostik und Verlaufsbeurteilung von Schilddrüsenerkrankungen. Internist 1995; 36: 303-309
22. Schumm-Draeger PM, Wenisch HJC. Methoden zum Nachweis von Schildddrüsenantikörpern. Akt Endokr Stoffw 1989; 10: 90-102
23. Senekowitsch-Schmidtke R, Schwaiger M. Zum Auftreten einer Immunhyperthyreose nach Radioiodtherapie von Schilddrüsenautonomien. Med Klin 1997; 92: 130-137
24. Soule J, Mayfield R. Graves' disease after 131I therapy for toxic nodule: Thyroid 2001; 10: 91-92
25. Studer H, Peter HJ, Gerber H. Morphologic and functional changes in developing goiters. In: Studer H (ed). Thyroid Disorders Associated with Iodine Deficiency and Excess. 1st ed. New York: Raven Press, 1985: 227-240
26. Vitti P, Rago T, Mazzeo S, Brogioni S, Lampis M, De Liperi A, Bartolozzi C. Thyroid blood flow by color-flow doppler sonography distinguishes Graves' disease from Hashimoto's thyroiditis. J Endocrinol Invest 1995; 18: 857-861
27. Wallaschofski H, Orda C, Georgi P, Miehle K, Paschke R. Distinction between autoimmune and non-autoimmune hyperthyroidism by determination of TSH-receptor antibodies in patients with the initial diagnosis of toxic multinodular goiter. Horm Metab Res 2001; 33: 504-507
28. Wallaschofski H, Müller D, Georgi P, Paschke R. Induction of TSH-receptor antibodies in patients with toxic multinodular goitre by radioiodine treatment. Horm Metab Res 2002; 34: 36-39